We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Hemochromatosis and Iron Overload Screening Study (HEIRS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00005541
Recruitment Status : Completed
First Posted : May 26, 2000
Last Update Posted : April 14, 2016
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)

Brief Summary:
To determine the prevalence, genetic and environmental determinants, and potential clinical, personal, and societal impact of iron overload and hereditary hemochromatosis, in a multi-center, multiethnic, primary care-based sample of 100,000 adults. The study is conducted by the Division of Epidemiology and Clinical Applications of the NHLBI, the Division of Blood Diseases and Resources of the NHLBI, and the Ethical, Legal, and Social Implications (ELSI) Research Program of the NHGRI.

Condition or disease
Blood Disease Hemochromatosis Iron Overload

  Show Detailed Description

Study Type : Observational
Study Start Date : January 2000
Primary Completion Date : January 2006
Study Completion Date : January 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hemochromatosis Iron
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   25 Years to 100 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
No eligibility criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00005541

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
OverallOfficial: Ronald Acton University of Alabama at Birmingham
OverallOfficial: Paul Adams London Health Sciences Centre
OverallOfficial: John Eckfeldt University of Minnesota - Clinical and Translational Science Institute
OverallOfficial: Victor Gordeuk Howard University
OverallOfficial: Emily Harris Kaiser Foundation Research Institute
OverallOfficial: Christine McLaren University of California
OverallOfficial: David Reboussin Wake Forest University

Study Data/Documents: Individual Participant Data Set  This link exits the ClinicalTrials.gov site
Identifier: HEIRS
NHLBI provides controlled access to IPD through BioLINCC. Access requires registration, evidence of local IRB approval or certification of exemption from IRB review, and completion of a data use agreement.

ClinicalTrials.gov Identifier: NCT00005541     History of Changes
Other Study ID Numbers: 5083
First Posted: May 26, 2000    Key Record Dates
Last Update Posted: April 14, 2016
Last Verified: April 2009

Additional relevant MeSH terms:
Iron Overload
Hematologic Diseases
Iron Metabolism Disorders
Metabolic Diseases
Metal Metabolism, Inborn Errors
Metabolism, Inborn Errors
Genetic Diseases, Inborn